(Q39149865)

English

Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell

scientific article published on 19 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell (English)

1 reference

Europe PubMed Central

9 September 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

bladder neoplasm

1 reference

based on heuristic

inferred from title

author name string

Conghui Han

1

1 reference

Europe PubMed Central

9 September 2017

Lin Hao

2

1 reference

Europe PubMed Central

9 September 2017

Meng Chen

3

1 reference

Europe PubMed Central

9 September 2017

Jianpeng Hu

4

1 reference

Europe PubMed Central

9 September 2017

Zhenduo Shi

5

1 reference

Europe PubMed Central

9 September 2017

Zhiguo Zhang

6

1 reference

Europe PubMed Central

9 September 2017

Bingzheng Dong

7

1 reference

Europe PubMed Central

9 September 2017

Yu Fu

8

1 reference

Europe PubMed Central

9 September 2017

Changsong Pei

9

1 reference

Europe PubMed Central

9 September 2017

Yongping Wu

10

1 reference

Europe PubMed Central

9 September 2017

publication date

19 May 2013

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

34

1 reference

Europe PubMed Central

9 September 2017

2863-2869

1 reference

Europe PubMed Central

9 September 2017

5

1 reference

Europe PubMed Central

9 September 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-0847-3

0 references

Epidemiology and risk factors of urothelial bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Immunotherapy of genitourinary malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Virus therapy for bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Anti-tumor function of double-promoter regulated adenovirus carrying SEA gene, in the treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Mechanism of monoclonal antibody-coupled Staphylococcus superantigen-A induced apoptosis in human bladder cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Gene therapy by membrane-expressed superantigen for alpha-fetoprotein-producing hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Tumor cells with B7.1 and transmembrane anchored staphylococcal enterotoxin A generate effective antitumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Syrian hamster tumor model to study oncolytic Ad5-based vectors.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0847-3

21 January 2018

Telomerase activity in human bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Telomerase activity in human urothelial tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A first in human phase 1 study of CG0070, a GM-CSF expressing oncolytic adenovirus, for the treatment of nonmuscle invasive bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/23686803

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-0847-3

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39149865&oldid=1809644127"